Amgen Inc. (AMG.DE)
XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
As of 01:25PM CEST. Market open.
| Previous close | 248.95 |
| Open | 247.80 |
| Bid | 246.85 x 20000 |
| Ask | 247.75 x 9000 |
| Day's range | 246.20 - 247.90 |
| 52-week range | 196.60 - 306.00 |
| Volume | |
| Avg. volume | 582 |
| Market cap | 132.914B |
| Beta (5Y monthly) | 0.60 |
| PE ratio (TTM) | 21.18 |
| EPS (TTM) | 11.70 |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | 8.29 (3.33%) |
| Ex-dividend date | 16 May 2024 |
| 1y target est | N/A |
ZacksAmgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights
Amgen (AMGN) concluded the recent trading session at $264.07, signifying a -0.59% move from its prior day's close.
PR NewswireAMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024
Amgen (NASDAQ:AMGN) today provided an update regarding the results of the Phase 2a COURSE trial for TEZSPIRE® (tezepelumab-ekko) in chronic obstructive pulmonary disease (COPD), which were accepted for presentation in the Clinical Trials Symposium at The American Thoracic Society (ATS) 2024 International Conference on Monday, May 20, from 9:15-11:15 a.m. PDT.
ZacksAmgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
© 2024 Yahoo. All rights reserved.